Products
VibroSense Meter II The VibroSense Meter II is built on advanced technology to measure and a
vibrosense.comCrawled Nov 21, 2026
VibroSense Meter II The VibroSense Meter II is built on advanced technology to measure and a
Cancer and Chemotherapy Over the past 20 years, there has been significant progress in the treatment of cancer. The use of chemotherapy increases gradually and the specialists agree that chemotherapy will continue to be included in the treatment.
Peer Reviewed Publications
Calendar VibroSense will participate at the upcoming below listed events during 2024/2025. The list is updated regularly.
Research links improved HbA1c levels to better tactile perception in diabetic patients using VibroSense’s Multi-Frequency Vibrometry and VibroSense Meter.
Studies with VibroSense Dynamics AB suggest its instruments may detect early neurological changes in diabetes and chemotherapy-treated cancer.
The senior specialist at Skåne University Hospital, Dr. Eero Lindholm, will present study results showing that it may be possible to reverse nerve damage in feet caused by diabetes by improved metabolic control. VibroSense Dynamics participates as an exhibitor at EASD in Hall 4 at booth 4J05.
The European Innovation Council and Medtronic hosted a 2018 event to discuss healthcare transformation and foster business partnerships. VibroSense presented solutions for detecting nerve injuries in hands and feet caused by diabetes or chemotherapy.
VibroSense History
The company invites meetings to discuss and demonstrate its systems.
The company states its systems require minimal support; users can contact them directly for issues.
For the Cookie Policy, see paragraph 11 below.
Disclaimer The information on this web site has been provided by VibroSense Dynamics AB as is.